Department of Epidemiology, School of Public Health, Sun Yat-Sen University, Guangzhou 510080, Guangdong, China.
Medical College, Shaoguan University, Shaoguan 512000, Guangdong, China.
Int J Environ Res Public Health. 2021 Feb 18;18(4):1993. doi: 10.3390/ijerph18041993.
Vaccination is a key strategy to prevent the pandemic caused by the coronavirus disease 2019 (COVID-19). This study aims to investigate the willingness of Chinese adults to be vaccinated against COVID-19 and further explore the factors that may affect their willingness. We used a self-design anonymous questionnaire to conduct an online survey via the Sojump. A total of 1009 valid questionnaires were analyzed. The age of the participants ranged from 18 to 74. Among them, 609 (60.4%, 95%CI: 57.4-63.4%) were willing to receive the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine. Logistic regression analysis results showed that the age of 30-49 (OR = 2.042, 95%CI: 1.098-3.799), universities and colleges education (OR = 1.873, 95% CI = 1.016-3.451), master degree or above education (OR = 1.885, 95%CI = 1.367-2.599), previous influenza vaccination history (OR = 2.176, 95%CI: 1.474-3.211), trust in the effectiveness of the vaccine (OR = 6.419, 95%CI: 3.717-11.086), and close attention to the latest news of the vaccine (OR = 1.601, 95%CI: 1.046-2.449) were facilitative factors that affected their willingness to be vaccinated. More than half of the adults in China would be willing to receive a SARS-CoV-2 vaccine. Middle-aged people with higher education, those who had been vaccinated against influenza, and those who believed that COVID-19 vaccine was effective and paid close attention to it were more willing to be vaccinated. Our findings can provide reference for the implementation of vaccination and the prevention of COVID-19 in China. More studies are needed after the vaccine is launched.
接种疫苗是预防 2019 年冠状病毒病(COVID-19)大流行的关键策略。本研究旨在调查中国成年人接种 COVID-19 疫苗的意愿,并进一步探讨可能影响其意愿的因素。我们使用自行设计的匿名问卷通过 Sojump 进行了在线调查。共分析了 1009 份有效问卷。参与者的年龄在 18 至 74 岁之间。其中,609 人(60.4%,95%CI:57.4-63.4%)愿意接受严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)疫苗。Logistic 回归分析结果表明,年龄在 30-49 岁(OR = 2.042,95%CI:1.098-3.799)、大学及大专教育(OR = 1.873,95%CI = 1.016-3.451)、硕士及以上学历(OR = 1.885,95%CI = 1.367-2.599)、有流感疫苗接种史(OR = 2.176,95%CI:1.474-3.211)、对疫苗有效性的信任(OR = 6.419,95%CI:3.717-11.086)、密切关注疫苗最新消息(OR = 1.601,95%CI = 1.046-2.449)是影响其接种意愿的促进因素。中国有超过一半的成年人愿意接种 SARS-CoV-2 疫苗。具有较高教育水平的中年人、曾接种过流感疫苗的人、以及认为 COVID-19 疫苗有效的人,以及密切关注疫苗的人更愿意接种疫苗。我们的研究结果可为中国实施疫苗接种和预防 COVID-19 提供参考。疫苗推出后还需要开展更多研究。